OncoSec Medical Inc (ONCSQ)

Currency in USD
0.042
0.000(0.00%)
Closed·
ONCSQ Scorecard
Full Analysis
Stock generally trades with low price volatility
Trading near 52-week High
Fair Value
Day's Range
0.0420.042
52 wk Range
0.0420.042
Key Statistics
Prev. Close
-
Open
0.042
Day's Range
0.042-0.042
52 wk Range
0.042-0.042
Volume
-
Average Volume (3m)
36.74K
1-Year Change
44.83%
Book Value / Share
-
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
ONCSQ Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Suffers from weak gross profit margins

OncoSec Medical Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Technical Indicators
Strong Buy
Moving Averages
Neutral

OncoSec Medical Inc Company Profile

OncoSec Medical Incorporated, a late-stage immuno-oncology company, focuses on designing, developing, commercializing intra-tumoral DNA-based therapeutics to stimulate and augment anti-tumor immune responses for the treatment of cancer. The company’s product pipeline includes KEYNOTE-695, which is in Phase 2 trial for the treatment of advanced melanoma; TAVO + SARS-CoV-2 spike glycoprotein, which is in Phase 1 clinical trial for the treatment of COVID-19; and TAVO + epacadostat + pembrolizumab, which is in Phase 1 clinical trial for the treatment of squamous cell carcinoma head and neck cancer. Its pipeline also comprises TAVO +nivolumab, which is in Phase 2 clinical trial for the treatment of breast cancer; TAVO + CXCL9 for the treatment of solid tumors; and OMS-100 and OMS-102, which are in Phase 2 clinical trial for the treatment of metastatic melanoma. OncoSec Medical Incorporated has clinical trial collaborations with Merck & Co., Inc. and its subsidiary in connection with the KEYNOTE-695 and KEYNOTE-890; and a research collaboration with Duke University’s Center for Applied Therapeutics to evaluate TAVO in combination or sequenced with a HER2-plasmid vaccine. The company was formerly known as NetVentory Solutions Inc. and changed its name to OncoSec Medical Incorporated in March 2011. OncoSec Medical Incorporated was incorporated in 2008 and is headquartered in Pennington, New Jersey. On June 14, 2023, OncoSec Medical Incorporated filed a voluntary petition for liquidation under Chapter 7 in the U.S. Bankruptcy Court for the District of New Jersey.

Compare ONCSQ to Peers and Sector

Metrics to compare
ONCSQ
Peers
Sector
Relationship
P/E Ratio
0.0x−4.7x−0.5x
PEG Ratio
0.000.000.00
Price/Book
0.0x2.1x2.6x
Price / LTM Sales
0.0x9.5x3.2x
Upside (Analyst Target)
0.0%171.3%41.7%
Fair Value Upside
Unlock9.7%6.1%Unlock

Earnings

Latest Release
Mar 14, 2023
EPS / Forecast
-2.65 / -0.1522
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

ONCSQ Income Statement

FAQ

What Stock Exchange Does OncoSec Medical Trade On?

OncoSec Medical is listed and trades on the OTC Markets stock exchange.

What Is the Stock Symbol for OncoSec Medical?

The stock symbol for OncoSec Medical is "ONCSQ."

What Is the OncoSec Medical Market Cap?

As of today, OncoSec Medical market cap is 250.43K.

What Is OncoSec Medical's Earnings Per Share (TTM)?

The OncoSec Medical EPS (TTM) is -14.77.

From a Technical Analysis Perspective, Is ONCSQ a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Buy.

How Many Times Has OncoSec Medical Stock Split?

OncoSec Medical has split 4 times.

How Many Employees Does OncoSec Medical Have?

OncoSec Medical has 41 employees.

What is the current trading status of OncoSec Medical (ONCSQ)?

As of 26 Jul 2025, OncoSec Medical (ONCSQ) is trading at a price of 0.04, with a previous close of 0.00. The stock has fluctuated within a day range of 0.04 to 0.04, while its 52-week range spans from 0.04 to 0.04.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.